Recent Updates
Recently added Catalysts
ACH Negative Sentiment

Accendra Health Receives Delisting Notice From the New York Stock Exchange

Key Takeaway: Accendra Health, Inc. announced that it received a delisting notice from the NYSE on November 16, 2026. The NYSE suspended trading of the company's common stock and initiated proceedings for delisting. This action follows Rule 802.01D of the NYSE Listing Standards.

Market Sentiment Analysis

CONCERNS & RISKS

  • Accendra Health's stock trading suspended immediately.
  • NYSE has commenced proceedings to delist the stock.

Full Press Release Details

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced that it received notification from the New York Stock Exchange (“NYSE”) on November 16, 2026, informing it that trading of the Company’s common stock on the NYSE was suspended, effective immediately, and that the NYSE has determined to commence proceedings to delist the Company’s common stock. The NYSE reached its decision to delist the Company’s common stock pursuant to Rule 802.01D of the NYSE Li

Frequently Asked Questions

Why was Accendra Health's stock suspended?

The NYSE suspended trading due to delisting proceedings.

When did the NYSE notify Accendra Health?

The notification was received on November 16, 2026.

What rule did the NYSE invoke for delisting?

The NYSE invoked Rule 802.01D for the delisting.

What does delisting mean for investors?

Delisting means the stock will no longer be traded on the NYSE.

Last updated: Nov 17, 2026